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Abstract
Cancer chemoprevention by natural dietary agents has received considerable importance because of their cost-
effectiveness and wide safety margin. However, single agent intervention has failed to bring the expected outcome in
clinical trials; therefore, combinations of chemopreventive agents are gaining increasing popularity. The present study aims
to evaluate the combinatorial chemopreventive effects of resveratrol and black tea polyphenol (BTP) in suppressing two-
stage mouse skin carcinogenesis induced by DMBA and TPA. Resveratrol/BTP alone treatment decreased tumor incidence
by ,67% and ,75%, while combination of both at low doses synergistically decreased tumor incidence even more
significantly by ,89% (p,0.01). This combination also significantly regressed tumor volume and number (p,0.01).
Mechanistic studies revealed that this combinatorial inhibition was associated with decreased expression of phosphorylated
mitogen-activated protein kinase family proteins: extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase 1/2, p38
and increased in total p53 and phospho p53 (Ser 15) in skin tissue/tumor. Treatment with combinations of resveratrol and
BTP also decreased expression of proliferating cell nuclear antigen in mouse skin tissues/tumors than their solitary
treatments as determined by immunohistochemistry. In addition, histological and cell death analysis also confirmed that
resveratrol and BTP treatment together inhibits cellular proliferation and markedly induces apoptosis. Taken together, our
results for the first time lucidly illustrate that resveratrol and BTP in combination impart better suppressive activity than
either of these agents alone and accentuate that development of novel combination therapies/chemoprevention using
dietary agents will be more beneficial against cancer. This promising combination should be examined in therapeutic trials
of skin and possibly other cancers.
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Introduction
Since early in the history of medicine, an association between
diet and cancer has persisted. The most consistent findings on diet
as a determinant of several types of cancers risk prevention is the
association with consumption of fruits and vegetables [1]. To date,
hundreds of natural or synthetic compounds have been found to
possess promising cancer chemopreventive actions. When review-
ing the literature on the effects of several dietary agents in animal
and in vitro studies, there is ample evidence that specific
antioxidants and other phytochemicals present in foods of plant
origin protect against genotoxicity and other cancer-initiating or
-promoting processes [2,3].
The concept of using a combination of agents for cancer
chemoprevention has recently received much attention. Consider-
able evidence from laboratories studies suggests that combinations
of chemopreventive agents can be more effective for the prevention
of cancer than any single constituent. Recently, Xu et al. [4]showed
that combination treatment of curcumin and green tea catechins
prevent dimethylhydrazine-induced colon carcinogenesis rat model
more potently than each of the compounds alone. In another recent
study, genistein-selenium combination significantly inhibited
growth of LNCaP and PC3 cells in a dose- and time-dependent
manner by decreasing matrix metalloproteins-2 levels [5]. Zhou et
al. [6] identified the possible chemopreventive effects of soy and tea
components on prostate tumor progression in in vivo. The
combination of both synergistically inhibited final tumor weight
and metastasis and significantly reduced serum concentrations of
testosterone and dihydrotestosterone. Our laboratory is actively
investigating the hypothesis that combinations of food-based cancer
prevention strategies will be a highly effective strategy for the
reductionof carcinogenesis. Duringthis course we have investigated
that combination of pomegranate fruit extract and diallyl sulfide
synergistically inhibited mouse skin tumor growth through reduce
proliferation, inhibition of mitogen-activated protein kinase
(MAPKs) and nuclear factor- kappa B (NF-kB) signaling and
induction of apoptotic cell death [7]. Now, we have chosen to focus
our experimental efforts on resveratrol and black tea polyphenol
(BTP), two foods frequently cited to protect humans from skin
carcinogenesis [8,9].
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polyphenol is widely present in foods such as grapes, wine and
peanuts. One of the most striking biological activities of resveratrol
intensely investigated during the last years has been its anti-cancer
and anti-inflammation properties. These properties were first
appreciated when Jang et al. [10] demonstrated that resveratrol
possesses cancer-chemopreventive and cytostatic properties via the
three major stages of carcinogenesis, i.e. initiation, promotion and
progression. Since then, there has been a flurry of papers reporting
the implication of resveratrol in cancer chemoprevention through
a wide range of actions [11]. Most of the cancer chemopreventive
evidence for resveratrol is well documented in various cancers such
as those of hepatocellular, lung, skin and prostate by multiple
regulatory mechanisms [12,13,14,15]. Kundu et al. [16] showed
that resveratrol exert anti-tumor promoting in the 12-O-
tetradecanoylphorbol 13-acetate (TPA)- induced mouse skin
carcinogenesis model suppression of cyclooxygenase-2 expression
by blocking the activation of MAPKs and activator protein.
Previously study from our laboratory have reported that
resveratrol-induces apoptosis in 7, 12-dimethylbenz[a]anthracene
(DMBA)-initiated and TPA promoted, mouse skin tumors through
cell cycle arrest, activation of p53 activity and alteration of
apoptosis-related proteins [17].
Tea, the most widely consumed beverage has received a great
deal of attention because of its polyphenolic constituents known to
have strong antioxidants and inhibitory activity against tumori-
genesis [18]. Many studies have demonstrated the anti-inflamma-
tory and anti-tumor effects of BTP; it can inhibit proliferation and
metastasis and induce apoptosis in various malignant tumors,
including skin cancer, by modulating several different signal
pathways [19,20,21]. Epidemiological studies on black tea and
cancer are limited, but several investigators have demonstrated
positive correlations between black tea consumption and a lower
incidence of breast [22] and ovarian [23] cancer. BTP treatment
has been shown to induce apoptosis in prostate cancer cells by
induction of p53, down-regulation of NF-kB activity, causing a
change in the ratio of pro-and anti-apoptotic proteins and
inhibiting expression of activated MAPKs [24].
It is clear that resveratrol and BTP independently have
biological activities for cancer prevention purposes, however,
productive application of these two compounds in combination to
exert synergistic effects against cancer inflammation and growth of
tumor warrants further studies. Therefore, multiple properties of
resveratrol and BTP in cancer prevention lead us to assume a
more benefit in combining these two agents rather than the single
agents for cancer prevention and therapy. Thus the present study
was designed to investigate whether resveratrol in combination
with BTP at low doses synergistically suppress the DMBA-
initiated, TPA- promoted two-stage mouse skin tumors. Our
results clearly demonstrate that a combination of resveratrol and
BTP can synergistically inhibit the development and progression
of mouse skin tumors then their solitary treatment.
Materials and Methods
Materials
DMBA, TPA, resveratrol, b-actin (clone AC-74) and propi-
dium iodide (PI) were purchased from Sigma Chemical Co. (St.
Louis, USA). Annexin-V and PI fluorescein isothiocyanate
(FITC) detection Kit was purchased from BD (San Jose, CA,
USA). Purified BTP (.98% pure) was kindly gifted by M/S
Indfrag company, Bangalore, India. Hydroxylapatite and N, N-
dimethylformamide was purchased from Sisco Research Labo-
ratory (Mumbai, India). The mouse monoclonal total and
phospho specific antibodies for p38, p53, c-Jun N-terminal kinase
(JNK1/2) (Thr183/Tyr185), p44/42 MAPK (Thr202/Tyr204)
i.e extracellular signal-regulated kinase (ERK1/2) were pur-
chased from Cell Signaling Technology (Beverly, USA). Prolif-
erating cell nuclear antigen (PCNA) antibody was obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The rabbit
anti-mouse or goat anti-rabbit horse radish peroxidase (HRP)
conjugate secondary antibodies were obtained from Bangalore
Genei (Bangalore, India). The poly(vinylidene) fluoride (PVDF)
membranes were obtained from Millipore (Billerica, MA, USA).
Other used chemicals were of analytical grade and procured
locally.
Animals and treatments
Male, Balb/c mice (15–18 g body weight [b. wt.]) were
obtained from the Indian Institute of Toxicology Research
(Lucknow, India) animal breeding colony. Prior ethical approval
for the experiments was obtained from institutional ethical
committee. All animals were quarantined in polypropylene cages
under standard laboratory conditions (temperature 2362uC,
relative humidity 5565%, 12/12 h light/dark cycle) and were
fed solid pellet diet (Ashirwad, Chandigarh, India) and water ad
libitum. After a week of acclimatization animals were used for
further experiments.
Long term animal bioassay: For treatment, animals were
randomly divided into 6 groups consisting 25 animals in each.
Animals of all groups were carefully shaved on dorsal skin in the
interscapular region of 2 cm
2. DMBA (tumor initiator), TPA
(tumor promoter) and resveratrol were dissolved in acetone. In
brief, treatment was given as described below for 18 weeks of
duration to attain the entire period of skin tumorigenicity:
Group I- No treatment was given to the animals and served as
untreated controls.
Group II- DMBA+TPA (animals were treated with single
topical application of DMBA (52 mg/animal), one week later
followed by topical application of TPA (5 mg/animal) thrice in a
week throughout the experimental period and served as positive
controls).
Group III- Acetone+Resveratrol+BTP (200 mL acetone was
applied topically followed by topical treatment of 50 mM/
animal resveratrol to each animal and 0.2% BTP was given as
sole source of drinking fluid thrice a week).
Group IV- DMBA+TPA+resveratrol (50 mM/animal resvera-
trol was given topically to the animals as mentioned in group
III, rest of the treatments was same as in group II).
Group V-D M B A +TPA+BTP (treatment of DMBA was
similar as in group II after a week followed by TPA application
and 0.2% BTP supplementation as in group II and III,
respectively).
Group VI- DMBA+TPA+resveratrol+BTP (DMBA and TPA
application was same as in group II, resveratrol (25 mM/animal)
application and BTP (0.1%) supplementation as in group III).
During treatment period animals were carefully observed for any
change in b. wt., fluid/food intake and development of skin tumor.
Tumors .1 mm in diameter were considered in the cumulative
number if they persist for 2 weeks or more. After completion of 18
weeks of treatments duration, the regression of pattern of tumors
in terms of both number and volume were recorded up to 26
weeks in the animals of groups IV, V and VI (bearing tumor or
not). These were divided into 3 subgroups and treatment schedule
was as follow:
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further treatment was given to these groups.
Group IV B and C- comprises tumor bearing animals’ and
treatment of TPA+resveratrol and only TPA was withdrawn,
respectively.
Group V B and C- comprises tumor bearing animals’ and
treatment of TPA+BTP and only TPA was withdrawn,
respectively.
Group VI B and C- comprises tumor bearing animals’ and
treatment of TPA+resveratrol+BTP and only TPA was
withdrawn, respectively.
After completion of the study period (26 weeks), all the animals of
groups IV–VI (A–C) were first examined for tumor volume/
number regression and thereafter sacrificed. Tumor volume was
calculated per mouse in each group using formula V=D6d26p/
6, where D=bigger dimension and d=smaller dimension. Skin
from the painted area (with or without tumors) was excised out,
cleaned, snap frozen in liquid nitrogen, and stored at 280uC until
further use.
Synergy between resveratrol and BTP combination
The nature of the combined effects of resveratrol and BTP was
determined using the method described by Zhou et al. [6], based
on the principles described by Chou and Talalay [25]. In brief, the
expected value of combination effect between agent 1 and agent 2
is calculated as [(observed agent 1 value)/(control value)]6[(ob-
served agent 2 value)/(control value)]6(control value); and the
ratio is calculated as (expected value)/(observed value). A ratio of
.1 indicates a synergistic effect, and a ratio of ,1 indicates a less
than additive effect.
Short term animal bioassay: Animals were divided into 6 groups
of 5 in each and doses for selected treatments was same as detailed
in long term study section for 2 weeks period. Briefly, groups and
treatments are as below:
Group I: Untreated control (No treatment).
Group II: DMBA+TPA (single dose of DMBA was applied
topically one week later followed by TPA application 4 times in
a week).
Group III: Acetone+resveratrol+BTP (animals were treated
with acetone and 50 mM resveratrol topically, and 0.2% BTP as
sole source of drinking fluid for 4 times in a week).
Group IV:D M B A +TPA+resveratrol (DMBA and TPA
application as in Gr. II and resveratrol treatment as in group
III).
Group V: DMBA+TPA+BTP (DMBA and TPA application as
in Gr. II and BTP supplementation as in group III).
Group VI: DMBA+TPA+resveratrol+BTP (DMBA and TPA
application as in Gr. II and, resveratrol (25 mM/animal) and
BTP (0.1%) treatment as in group III).
At the end of the experimental period all the animals were
sacrificed and skin from the painted area was excised out, cleaned,
snap frozen in liquid nitrogen, and stored at 280uC until further
use.
Preparation of lysates
Whole skin tissue/tumor homogenates (10%) were made as
described by Kataoka et al. [26], in both, the long term as well as
the short term study. The supernatants were collected and stored
at 280uC till use.
Western blotting
Western blotting was carried out as described earlier [27].
Protein concentration was measured following standard protocols
[28]. Proteins (60 mg) were resolved on 10–12% SDS PAGE and
electroblotted on PVDF membrane. The blots were blocked
overnight with 5% non-fat dry milk and probed with antibodies at
dilutions recommended by the suppliers. Immunoblots were
detected through chemiluminescence using kit of Millipore
(Billerica, MA, USA).
Histopathological analysis
Paraffin sections (5 mm) of the skin tissues/tumors were stained
with haematoxylin and eosin for histopathological analysis. Histo-
pathological observations were made according to Bogovaski [29].
Immunohistochemical (IHC) staining
Buffered formalin fixed and paraffin embedded skin/tumor
tissues were cut into sections (5 mm thick), which were subse-
quently de-waxed and hydrated. Then endogenous peroxidase
activity was quenched and epitope retrieval was performed. This
was followed by blocking of non-specific binding of primary
antibody to epitopes by a preincubation step with normal serum.
Sections were then incubated overnight with the primary
monoclonal anti-PCNA (1:100) antibody. After incubation, the
sections were again incubated with normal serum and then with
HRP-conjugated secondary antibody. The colour was developed
using substrate chromogen system diaminobenzidine (Dako, CA,
USA). For the negative control, phosphate-buffered saline was
used in place of the primary antibody. The immunostained slides
were analyzed under microscope (Leica, Wetzler, Germany)
attached with charge coupled device camera (JVC).
Annexin-V and PI dual staining
Annexin-V and PI FITC detection Kit (BD, San Jose, CA, USA)
was used for the differentiation between apoptotic and necrotic cell
population. The single cell suspensions of treatedand untreated skin
tissues (from short term study) were prepared using Medimachine
(Beckton Dickinson, San Jose, USA). For each sample, Annexin-V/
PI fluorescence was analyzed, wherein fluorescence of cells was
gated and counted using ‘Cell Quest 3.1 software’.
DNA alkaline unwinding assay
Strand breaks in cellular DNA were quantitated by alkaline
unwinding assay using hydroxyapatite batch procedure as
described previously [30]. In brief, 100 mg of DNA from treated
and untreated skin tissue samples (from short term study) was
subjected to alkaline unwinding and the relative amount of duplex
and single stranded DNA present at the end of the alkaline
unwinding was quantified.
Statistical analysis
For the statistical analysis of skin tumor appearance dynamics,
the Kaplan-Meier method of tumor-free survival estimation was
applied. Statistically significant differences were determined
between control and treatment groups using one-way ANOVA
(GraphPad Prism software) followed by Dunnett post hoc test.
Values with p,0.05 were considered significant.
Results
Effects of resveratrol and/or BTP on tumorigenicity rate
The b. wt. of each animal was recorded every week during the
entire period of the experiment. Compared with the untreated
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showed a significant reduction in b. wt. However, there was an
increasing percentage of change in the b. wt. gain of the animal of
the experimental treatments (groups III–VI) (data not shown).
The first day of tumor incidence in the positive control (DMBA
and TPA) group II was 48th day; however, it was 63th day in
resveratrol treated group IV, 58th day in BTP treated group V
and 84th day in the resveratrol and BTP treated group VI. There
was no tumor induction in group III. The chemopreventive
potential of resveratrol and BTP was also evident by significant
(p,0.01) increase in tumor free survival of animals. 36%, 48%
and 72% of animals of group IV, V and VI, respectively,
remained tumor-free till the termination of the experiment.
However, in positive control group (II) 100% animals were
observed with tumors by the end of 18th week (Figure 1A). The
expected effect of the resveratrol/BTP combination on tumor-
igenicity rate (33%) was greater than the observed combination
effect (28%) with a ratio of 1.17, suggesting that the resveratrol/
BTP combination had a synergistic inhibitory effect on
tumorigenicity (Table 1).
Protection was also seen in terms of reduction in tumor
volume. The tumor volume was 130.0 mm3/mouse in DMBA
and TPA group, which reduced to 52.6, 63.2 and 24.6 mm3/
mouse in group IV, V and VI, respectively. The expected effect
of the combined resveratrol and BTP on average tumor volume
(19.7%) was higher than the observed combined effect (18.9%)
with a ratio of 1.05, suggesting that resveratrol and BTP
combination also had synergistic effect in reducing the tumor
volume (Table 1).
Protection afforded by resveratrol and BTP was also evident in
terms of reduction in the cumulative number of tumors (CNT).
While the positive control group showed 230 CNT, group IV, V
and VI showed 71, 89, and 25 CNT, respectively, at 18th week
(Figure 1B). The observed effect (10.9%) in combination group VI
was less than the expected value (11.9%), with ratio of 1.09,
suggesting that resveratrol and BTP combination synergistically
reduces CNT (Table 1).
When these tumor data were considered in terms of number of
tumors per mice, at the termination of the experiment at 18 weeks on
test, compared with 9.2 tumors per mouse in DMBA and TPA treated
group, 4.4, 5.7 and only 2.5 tumors per mouse in group was recorded
in group IV, V and VI, respectively (Figure 1C). Compared with the
solitary resveratrol (75%) and BTP (67%) treated groups, decrease in
the number of tumor per mouse in combination-treated group
corresponded to 89% inhibition. The observed effect (27.2%) in
combination group VI was less than the expected value (29.6%), with
ratio of 1.08, suggesting that resveratrol and BTP combination also
synergistically reduces CNT (Table 1).
Effects of resveratrol and/or BTP on tumor growth and
regression
We further extended the work to observe regression offered by
combined doses of resveratrol and BTP in tumor volume and
number if any. At 19th week, TPA treatment was ceased and
Figure 1. Effect of resveratrol and/or BTP on DMBA and TPA-induced mouse skin tumors. (A) Percentage of tumor-free survival, (B)
cumulative number of tumors (CNT) per group, (C) reduction in average no. of tumors/mouse and (c) reduction in tumor volume/mouse (mm
3). The
data showed are of surviving animals upto 18
th weeks in (A), (B) and (C) however, mean6SD of surviving animals from 18
th to 26
th weeks in (D).
* indicates significant reduction over DMBA and TPA treated group II at 18
th week (p,0.01). ** indicates significant reduction over resveratrol and
BTP alone treated groups at 18
th week (p,0.01). *** indicates significant reduction after 26
th weeks (p,0.01).
doi:10.1371/journal.pone.0023395.g001
Combined Resveratrol and BTP Inhibit Skin Tumors
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23395morphological changes of the tumors were recorded in group IV
B, IV C, V B, V C, VI B and VI C. Among these groups, in Gr. VI
C, major commencement of regression was recorded from 22
nd
week onwards (p,0.01). Apparently, group VI B from which
resveratrol and BTP were withdrawn showed regression in terms
of both tumor volume and number (Table 2). The tumor volume
at 26th week reduced to 105.4 mm
3/mouse in DMBA and TPA
group II, 21.8 mm
3/mouse in group VI B and 18.9 mm
3/mouse
in group VI C (Table 2, Figure 1D). CNT reduced to 198, 10 and
6 in group II, VI B and VI C, respectively (Table 2). Changes in
both tumor number and volume were also observed in solitary
resveratrol and BTP treated groups (IV B, IV C, V B and V C) but
the extent was lesser than combination (Table 2, Figure 1D).
Moreover, animals of group VI A did not show any morphological
changes as well as development of tumors till the termination of
the experiment (Table 2). Thus, combined supplementation of
resveratrol and BTP resulted in regression in both tumor volume
and number and imparts better efficacy in terms of tumor
regression then either of these agents alone.
Effect of resveratrol and/or BTP on phosphorylated
MAPKs
It has been reported that topical application of TPA in mouse
skin results in a marked increase in the phosphorylated form of
MAPKs [31], affecting fundamental cellular processes like prolif-
eration, differentiation, and survival, thus we further evaluated the
expression levels of MAPK family proteins [32]. In the present
study, western blot analysis showed that the activation of MAPKs
(ERK1/2 , JNK1/2 and p38) was gradually increased during
progression of TPA-induced papillomagenesis in DMBA-initiated
mouse skin over untreated control group (p,0.05), in both long and
short term studies (Figure 2A and B). However, supplementation of
Table 1. Possible synergistic chemopreventive effect of the interaction between Res and BTP against DMBA and TPA-induced
mouse skin tumorigenesis.
Treatment (Groups) Tumorigenicity (%) CNT (%) ANT (%) ATV (%)
OE
a R
b OE
a R
b OE
a R
b OE
a R
b
Untreated control (I)
DMBA+TPA (II) 100.0 100.0 100.0 100.0
Acetone+Res+BTP (III)
DMBA+TPA+Res (IV) 64.0 30.9 47.8 40.5
DMBA+TPA+BTP (V) 52.0 38.7 62.0 48.6
DMBA+TPA+Res+BTP (VI) 28.0 33.0 1.17 10.9 11.9 1.09 27.1 30.0 1.08 18.9 19.7 1.03
All the data are statistically significant, p,0.01.
aExpected value of Res and BTP combination=[(observed value of Res)/(control value)]6[(observed value of BTP)/(control value)]6(control value).
bRatio=(expected value/observed value). A ratio of.1 indicates a synergistic effect, and a ratio of ,1 indicates a less than additive effect.
O, observed; E, expected; R, ratio; Res, resveratrol; CNT, cumulative number of tumors; ANT, average number of tumors/mouse; ATV, average tumor volume/tumor
bearing mouse.
doi:10.1371/journal.pone.0023395.t001
Table 2. Combinatorial chemopreventive effect of Res and/or BTP on tumor regression.
Groups Treatment
Number of
animals with
tumors CNT
ANT
(Mean ± SD)
ATV
(Mean ± SD)
18th 26th 18th 26th 18th 26th 18th 26th
II DMBA+TPA 25/25 25/25 230 198 9.262.6 7.9262.1 130.0610.2 105.4610.4
IV A (2)Res-Non-tumor bearing 0/12 0/12 - - - - - -
IV B (2)Res-tumor bearing 6/6 6/6 34
a 28
a 5.6661.9
a 5.6662.0
a 56.167.2
a 51.866.0
a
IV C (+)Res-tumor bearing 7/7 7/7 35
a 26
a 5.0061.1
a 3.7162.5
a 49.166.1
a 40.365.5
a
VA (2)BTP-Non-tumor bearing 0/9 0/9 - - - - - -
VB (2)BTP-tumor bearing 8/8 8/8 42
a 36
a 5.2562.1
a 4.562.2
a 59.366.2
a 50.866.6
a
VC (+)BTP-tumor bearing 8/8 8/8 46
a 34
a 5.7562.1
a 4.262.6
a 67.165.4
a 53.667.5
a
VI A (2)Res+BTP-Non-tumor bearing 0/13 0/13 - - - - - -
VI B (2)Res+BTP-tumor bearing 5/5 5/5 13
b 10
b 2.662.0
b 2.062.0
c 24.265.4
b 21.865.6
c
VI C (+)Res+BTP-tumor bearing 5/5 3/5 12
b 6
b 2.461.6
b 2.061.6
c 23.967.4
b 18.968.6
c
asignificant reduction over DMBA and TPA treated group II at 18th week (p,0.01).
bsignificant reduction over BTP and Res alone treated groups IV B–C and V B–C at 18th week (p,0.01).
csignificant reduction at 26th week (p,0.01).
(2) indicates without treatment, (+) indicates with treatment.
Res, resveratrol; CNT, cumulative number of tumors; ANT, average number of tumors/mouse; ATV, average tumor volume/tumor bearing mouse.
doi:10.1371/journal.pone.0023395.t002
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TPA treated animals, significantly (p,0.05) down-regulated the
expression levels of ERK1/2, JNK1/2 and p38 through inhibition
of theirphosphorylationas compared toanimals of groupII,inboth
experimentalsets(Figure 2AandB).Therewasnoeffectonthetotal
amount of ERK1/2, JNK1/2 and p38 proteins after DMBA and
TPA treatment (Figure 2A and B).
Effect of resveratrol and/or BTP on histopathology of
skin/tumor
Histologically skin tumor sections from DMBA and TPA
applied group II exhibited varying degrees of structural and
cytological changes as compared to untreated control group I
(Figure 3A). Tumors section of group II animals exhibit focal
proliferation of squamous cells, presence of some necrotic cells and
Figure 2. Western blots showing the inhibitory effect of resveratrol and/or BTP on the expression levels of total and phospho-
ERK1/2, JNK1/2 and p38 in mouse skin tumors. (A) Long and (B) short term studies. Details for groups and treatments are described in
Materials and methods section. The bands shown here are from a representative experiment repeated three times with similar results. Equal
loading was confirmed by stripping the immunoblot and reprobing it for b-actin. The pixel density of the specific immunoreactive bands was
quantified by densitometry and expressed as a fold difference against b-actin. * more than corresponding value of untreated control group I
(p,0.05). **less than corresponding value of DMBA and TPA group II (p,0.05).
# less than corresponding value of BTP and Res alone treated
groups IV and V (p,0.05).
doi:10.1371/journal.pone.0023395.g002
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of tumors initiated and promoted by DMBA and TPA,
respectively. However, skin sections from animals treated with
resveratrol/BTP (group III), did not reveal any histopathological
abnormalities (Figure 3A). The administration of both resveratrol
and BTP led to suppression of DMBA and TPA induced skin
tumorigenesis which was evident by skin/tumor sections
(Figure 3A). Skin tumor sections of group VI showed chances
towards normalization of skin as compared to group II (Figure 3A).
Similarly, in short term experimental groups’ haematoxylin and
eosin stained sections were showing pronounced preventive effects
of resveratrol and BTP treatment when given in combination than
alone over DMBA and TPA -induced changes in animals skin
(Figure 3B). In group II, disorganization of epithelium, presence of
necrotic cells and focal proliferative area were noticed as
compared to group I (Figure 3B).
Effect of resveratrol and/or BTP on proliferation marker
IHCanalysisofPCNAwasused toassesstheproliferationactivity
during tumor promotion (Figure 3A). PCNA reactivity is associated
with S phase of DNA replication [33]. It was observed that PCNA
labelling indices were higher in animals treated with DMBA and
TPA as compared to other groups. A characteristic intense staining
and higher number of PCNA positive cells were observed as shown
in Figure 4A. The representative untreated control group did not
show significant positive staining (Figure 4A). Further, treatment of
resveratrol and BTP resulted in low expression levels of PCNA
positive cells (p,0.01) as compared to group II revealing that effects
of combinational treatment of resveratrol and BTP were superior to
single treatment (Figure 4A).
Similarly, PCNA staining were analyzed to determine the
proliferative status of skin after treatment with DMBA and TPA
and the respective preventive treatments in short term groups
(Figure 4B). It was observed that the number of PCNA positive cells
were higher in animals of group II as compared to untreated animals
(Figure 4B). The skin sections from untreated animals did not show
significant positive staining for PCNA (p,0.01). Treatment with
either resveratrol or BTP or both in combination in DMBA and TPA
applied animals resulted in significantly low level of PCNA positive
cells (p,0.01) (Figure 4B).
Figure 3. Histological study of mouse skin/tumors. (A) Long and (B) short term experimental groups. Details for groups and treatments are
described in Materials and methods section.
doi:10.1371/journal.pone.0023395.g003
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stabilization of tumor suppressor protein, p53
p53 in response to toxic insults to DNA, triggers a chain of cell
cycle regulatory events to check the proliferation of altered cells to
repair or minimize the damage [34,35] and Ser 15 phosphory-
lation is essential for stabilization and activation of p53 [36]. To
determine whether p53 is phosphorylated at Ser15 in mouse skin
tumors (long term study) treated with resveratrol, BTP or their
combination, we used a phospho-specific antibody against p53 at
Ser15 to do Western blot analysis. Our data showed that the level
of p53 phosphorylation at Ser15 was increased in group IV and V
upon treatment with resveratrol and BTP as compared with
DMBA and TPA group II, however, significant increase in their
expression was observed in combination group VI (Figure 5).
Immunoblotting showed that the increased level of wild-type p53
protein corresponded well with the increased level of p53
Figure 4. Effects of resveratrol and BTP treatment on modulation of PCNA expression. (A) Long and (B) short term experiments. Details
are described in Materials and methods section. The brown colour nuclei mark the reactivity with PCNA indicated by arrows. Bar diagram shows mean
6 SD of three independent sets analysis. *significantly increased in comparison of group I (p,0.01), **significantly decreased when compared with
group II (p,0.01).
#significantly decreased when compared with groups IV and V (p,0.01).
doi:10.1371/journal.pone.0023395.g004
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earlier reports from our laboratory showing inhibitory effects of
resveratrol and BTP individually in DMBA induced mouse skin
tumors via enhancement of wild-type p53 [17,21]. These results
suggest that the combination of resveratrol and BTP more
efficiently stabilized p53 and induced its phosphorylation at
ser15 than either single agent.
Effect of resveratrol and/or BTP on apoptosis
Apoptosis is the most potent defence mechanism against cancer
[37]. We next quantified the extent of apoptosis by flow cytometric
analysis of the skin cells labelled with Annexin V/PI. Results
showed significant (p,0.05) percent increase in apoptotic
population by either resveratrol/BTP or the two in combination
(6.1260.34, 5.2360.52 and 14.0060.20, respectively) over
untreated (2.1060.36) and DMBA and TPA group II which
recorded 1.4060.15 apoptotic populations (Figure 6).
Effect of resveratrol and/or BTP on DMBA and TPA-
induced nick formation
Based on the amount of duplex DNA remaining after alkali
treatment, the number of strand breaks generated per unit DNA
was determined in mouse skin tissues obtained from short term
study. DMBA and TPA caused a significant DNA damage
(n=1.5060.17) over untreated (n=0.00760.001) in terms of
strand breaks (p,0.01). Inhibition of DMBA and TPA-induced
DNA alkylation damage was recorded by either resveratrol or
BTP or the two in combination and prevention percentage was
found to be 45.79%, 40.52% and 60.53%, respectively (Table 3).
Discussion
Chemoprevention by using dietary agents in combination is
gaining the attention of researchers and consumers as a plausible
approach for the management of various neoplasia. In this study,
employing two-stage mouse skin carcinogenesis protocol, we are
able to show that combined treatment of resveratrol (25 mM/
animal) and BTP (0.1%) synergistically suppressed the skin tumors
more efficiently than either of these solitary agents (Figure 1).
Administration of resveratrol and BTP in combination was found
to be highly effective in decreasing the CNT and tumor volume
(Table 2). Earlier studies from our laboratory have demonstrated
the chemopreventive potential of both the agents against mouse
skin carcinogenesis, respectively [17,21]. The central finding of the
study is that combined doses of resveratrol and BTP also resulted
in significant regression of tumors in regard to both tumor volume
and number. Also, no increase in tumor volume or occurrence of
tumors was observed in groups (tumor bearing and non tumor-
bearing) after withdrawal of the combined treatment. Hence, we
observed that resveratrol and BTP (in combination) had superior
chemopreventive effects as compared to either resveratrol or BTP.
MAPKs, comprising a family of serine and threonine kinases of
ERK, JNK, and p38, are important signaling components which
convert external stimuli into a wide range of cellular responses,
such as proliferation, survival, differentiation and migration [32].
MAPK signalling cascades are highly relevant in the process of
tumor promotion and progression induced by chemical carcino-
gens in mouse skin carcinogenesis, affecting not only cell
proliferation, but also apoptosis by promoting the survival of the
tumor cell [38,39]. Activation of the MAPKs pathway occurs in
Figure 5. Effects of resveratrol and BTP treatment on modulation of p53 expression and p53 phosphorylation and stabilization.
Details for groups and treatments are described in Materials and methods section. The bands shown here are from a representative experiment
repeated three times with similar results. Equal loading was confirmed by stripping the immunoblot and reprobing it for b-actin. The pixel density of
the specific immunoreactive bands was quantified by densitometry and expressed as a fold difference against b-actin. ** less than corresponding
value of untreated control group I (p,0.05). * more than corresponding value of DMBA and TPA group III (p,0.05).
# more than corresponding value
of BTP and Res alone treated groups IV and V (p,0.05).
doi:10.1371/journal.pone.0023395.g005
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matrix, which plays a critical role in both tumor metastasis and
angiogenesis [40,41]. In the present study, we found that topical
application of DMBA and TPA (Gr. II) resulted in a marked
increase in the phosphorylated form of ERK1/2, JNK1/2 and
p38 protein expression; however, resveratrol and/or BTP
treatment inhibited this phosphorylation. Importantly, the com-
bined administration of both resveratrol and BTP was found to be
more potent in inhibiting phosphorylation of MAPKs (Figure 2).
These findings suggest a possibility that as an initial response
resveratrol and BTP (in combination) modulate MAPKs activation
further leads to inhibition of tumor growth and regression by
apoptotic cell death.
In the present study, we further investigated the solitary and
combined effect of resveratrol and BTP on expression of
proliferation marker PCNA. Enhanced expression of PCNA, a
36 kDa co-factor of DNA polymerase d, is one of the downstream
effects of the activation of MAPK/ERK1/2 signalling and well
correlated to the status of cellular proliferation [42]. Although
single administration of resveratrol and BTP resulted in growth
inhibition of DMBA and TPA-induced skin tumors, their
combined treatment markedly inhibited the growth accompanying
significant decrease in PCNA immunoexpression in tumor
sections. Besides this, histologic analysis of the skin tissues of
untreated animals displays major epithelial proliferation. In
contrast the skin/tumor sections of mice given resveratrol and/
or BTP display no indication of neoplasia. Therefore, inhibition of
ERK1/2, JNK1/2 and p38 activation, suppression of PCNA upon
Figure 6. Representative figure of flow cytometric analysis of apoptosis in mouse skin on treatment with resveratrol and BTP. The
data is representative of three independent experiments (p,0.05). Details are described in Materials and methods section. Figure showing cells in the
upper right (UR), upper left (UL) and lower right (LR) portions portion of the picture indicates late apoptotic cells, necrotic and pre-apoptotic cells,
respectively whereas cells present in lower left (LL) portion of the picture indicate percentage of live cells.
doi:10.1371/journal.pone.0023395.g006
Table 3. Number of DNA strand breaks inhibited by
resveratrol or/and BTP against DMBA and TPA- induced DNA
alkylation damage.
Groups Treatment
Number of DNA strand
breaks (n)
II DMBA+TPA 1.5060.17
IV DMBA+TPA+resveratrol 0.8160.18
a (45.79%)
V DMBA+TPA+BTP 0.9060.19
a (40.52%)
VI DMBA+TPA+resveratrol+BTP 0.6060.14
b (60.53%)
Data are expressed as mean 6 SD of five animals. ‘n’ represents number of
strand breaks of duplex DNA over untreated control group.
asignificant prevention over DMBA and TPA- induced DNA strand breaks
(p,0.01).
bsignificant prevention over BTP and Res alone treated groups IV and
V(p,0.01).
Values in parenthesis represents the percentage prevention offered by
resveratrol or/and BTP against DMBA and TPA- induced DNA strand breaks.
doi:10.1371/journal.pone.0023395.t003
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alone treatments, suggest the superiority in synergistic effects of the
two. This finding is quite intriguing, and it is tempting to speculate
that a combination of resveratrol and BTP might have efficiently
more influenced the cell death–related signaling pathways,
ultimately leading to the suppression of well-established DMBA
and TPA induced tumor in vivo, which might not possibly be
achieved by a single administration of resveratrol or BTP.
To dissect the possible mechanisms in which the apoptotic and/
or anti-proliferation signaling were triggered, we also examined
the expression levels of the tumor suppressor p53 protein. p53
plays a crucial role in controlling the cell cycle, apoptosis, genomic
integrity and DNA repair in response to various forms of stress
[35]. As aforementioned, post-translational modifications such as
phosphorylation and acetylation are critical for stabilization and
activation of p53 [36] our data showed that phosphorylation of
p53 (Ser15) increased in mouse skin tumors treated with
resveratrol and BTP, but the combination induced more efficient
stabilization and phosphorylation of p53 protein at (Figure 5).
Consistent with the findings of our previous reports [17,21], wild-
type p53 activity also increased more in these groups
(Figure 5).Thus, indicate that in mouse skin tumors, growth
inhibition induced by resveratrol and/or BTP is p53-dependent
and induced p53 phosphorylation at Ser15 may be attributed to
stabilization of p53.
Apoptosis is a selective process of physiological cell deletion that
plays an important role in the balance between cellular replication
and death. Furthermore, it has been suggested that some cancer
chemotherapeutics and chemopreventives exert their effects by
triggering either apoptotic cell death or cell cycle transition, and
accordingly, the induction of tumor cell apoptosis is used to predict
tumor treatment response [43,44]. Therefore, we quantified the
extent of apoptosis by flow-cytometric analysis of skin cells labelled
with Annexin-V-PI. The results showed that combinatorial effect
of resveratrol and BTP, leads to enhanced cell death than either of
them alone. In addition, it is further noted that the administration
of resveratrol and/or BTP inhibited the DMBA and TPA-
induced DNA damage as revealed by the reduction in strand
breaks. But combination doses exerted better effects than either of
these two agents alone. This might be occurring because both of
them are known to have ability to repair DNA damage [45,46].
In recent years, emerging evidence suggests that cancer-
preventive agents might be combined for more effective treatment
of cancer [47]. They can react together to give synergistic action to
intervene cancer stages by different signaling pathways or to
compensate for the opposite properties in cancer cell proliferation
or apoptosis. Thus, we conclude that both resveratrol and BTP at
low doses in combination synergistically inhibit established skin
tumor growth than either of these agents alone accompanied by
decrease in tumor volume and number. This is attributable to
reduction in nick formation associated with a decrease in
proliferation marker and tumor suppressor protein p53 together
with an inhibition of MAPKs signaling and induction of apoptotic
cell death in skin cells. Further pre-clinical and clinical trials are
warranted to characterize the efficacy of dietary agents in
combination with existing therapeutics for chemoprevention and
chemotherapy of cancer.
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